These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 28931570

  • 1. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.
    Madsen PM, Pinto M, Patel S, McCarthy S, Gao H, Taherian M, Karmally S, Pereira CV, Dvoriantchikova G, Ivanov D, Tanaka KF, Moraes CT, Brambilla R.
    J Neurosci; 2017 Oct 18; 37(42):10185-10199. PubMed ID: 28931570
    [Abstract] [Full Text] [Related]

  • 2. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
    Yue Y, Stanojlovic M, Lin Y, Karsenty G, Lin W.
    J Neuroinflammation; 2019 Feb 01; 16(1):23. PubMed ID: 30709400
    [Abstract] [Full Text] [Related]

  • 3. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Feb 01; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 4. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.
    Lin Y, Huang G, Jamison S, Li J, Harding HP, Ron D, Lin W.
    Am J Pathol; 2014 Feb 01; 184(2):507-19. PubMed ID: 24269558
    [Abstract] [Full Text] [Related]

  • 5. Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis.
    Girolamo F, Ferrara G, Strippoli M, Rizzi M, Errede M, Trojano M, Perris R, Roncali L, Svelto M, Mennini T, Virgintino D.
    Neurobiol Dis; 2011 Sep 01; 43(3):678-89. PubMed ID: 21679768
    [Abstract] [Full Text] [Related]

  • 6. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
    Forte M, Gold BG, Marracci G, Chaudhary P, Basso E, Johnsen D, Yu X, Fowlkes J, Rahder M, Stem K, Bernardi P, Bourdette D.
    Proc Natl Acad Sci U S A; 2007 May 01; 104(18):7558-63. PubMed ID: 17463082
    [Abstract] [Full Text] [Related]

  • 7. Sustained ErbB Activation Causes Demyelination and Hypomyelination by Driving Necroptosis of Mature Oligodendrocytes and Apoptosis of Oligodendrocyte Precursor Cells.
    Hu X, Xiao G, He L, Niu X, Li H, Lou T, Hu Q, Yang Y, Xu Q, Wei Z, Qiu M, Tanaka KF, Shen Y, Tao Y.
    J Neurosci; 2021 Dec 01; 41(48):9872-9890. PubMed ID: 34725188
    [Abstract] [Full Text] [Related]

  • 8. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J, Zhang ZG, Li Y, Lu M, Zhang Y, Elias SB, Chopp M.
    Neurobiol Dis; 2016 Apr 01; 88():85-95. PubMed ID: 26805386
    [Abstract] [Full Text] [Related]

  • 9. Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons.
    Yool DA, Klugmann M, McLaughlin M, Vouyiouklis DA, Dimou L, Barrie JA, McCulloch MC, Nave KA, Griffiths IR.
    J Neurosci Res; 2001 Jan 15; 63(2):151-64. PubMed ID: 11169625
    [Abstract] [Full Text] [Related]

  • 10. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
    Lindner M, Fokuhl J, Linsmeier F, Trebst C, Stangel M.
    Neurosci Lett; 2009 Apr 03; 453(2):120-5. PubMed ID: 19356606
    [Abstract] [Full Text] [Related]

  • 11. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 03; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 12. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
    Oluich LJ, Stratton JA, Xing YL, Ng SW, Cate HS, Sah P, Windels F, Kilpatrick TJ, Merson TD.
    J Neurosci; 2012 Jun 13; 32(24):8317-30. PubMed ID: 22699912
    [Abstract] [Full Text] [Related]

  • 13. Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE.
    Chaudhary P, Marracci GH, Calkins E, Pocius E, Bensen AL, Scanlan TS, Emery B, Bourdette DN.
    J Neuroimmunol; 2021 Mar 15; 352():577468. PubMed ID: 33422763
    [Abstract] [Full Text] [Related]

  • 14. Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis.
    Tanabe S, Fujita Y, Ikuma K, Yamashita T.
    Cell Death Dis; 2018 Oct 17; 9(11):1061. PubMed ID: 30333477
    [Abstract] [Full Text] [Related]

  • 15. The deletion of dicer in mature myelinating glial cells causes progressive axonal degeneration but not overt demyelination in adult mice.
    Li T, Wang J, Wang H, Yang Y, Wang S, Huang N, Wang F, Gao X, Niu J, Li Z, Mei F, Xiao L.
    Glia; 2018 Sep 17; 66(9):1960-1971. PubMed ID: 29726608
    [Abstract] [Full Text] [Related]

  • 16. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO.
    Adv Exp Med Biol; 2017 Sep 17; 958():91-127. PubMed ID: 28093710
    [Abstract] [Full Text] [Related]

  • 17. The DTA Mouse Model for Oligodendrocyte Ablation and CNS Demyelination.
    Traka M.
    Methods Mol Biol; 2019 Sep 17; 1936():295-310. PubMed ID: 30820906
    [Abstract] [Full Text] [Related]

  • 18. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
    Stone S, Wu S, Jamison S, Durose W, Pallais JP, Lin W.
    Glia; 2018 Jul 17; 66(7):1331-1345. PubMed ID: 29436030
    [Abstract] [Full Text] [Related]

  • 19. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.
    Yamamoto S, Yamashina K, Ishikawa M, Gotoh M, Yagishita S, Iwasa K, Maruyama K, Murakami-Murofushi K, Yoshikawa K.
    J Neuroinflammation; 2017 Jul 21; 14(1):142. PubMed ID: 28732510
    [Abstract] [Full Text] [Related]

  • 20. Creatine Enhances Mitochondrial-Mediated Oligodendrocyte Survival After Demyelinating Injury.
    Chamberlain KA, Chapey KS, Nanescu SE, Huang JK.
    J Neurosci; 2017 Feb 08; 37(6):1479-1492. PubMed ID: 28069926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.